Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States

Devonshire IM, 2012, Neuroimage, 59, 1997, 10.1016/j.neuroimage.2011.09.050

Devonshire V, 2011, Eur J Neurol, 18, 69, 10.1111/j.1468-1331.2010.03110.x

10.1111/j.1528-1157.2000.tb00166.x

Pugliatti M, 2007, Epilepsia, 48, 2224, 10.1111/j.1528-1167.2007.01251.x

10.1212/WNL.51.5.1256

Kwan P, 2000, N Eng J Med, 342, 314, 10.1056/NEJM200002033420503

Kwan P, 2000, Seizure, 9, 464, 10.1053/seiz.2000.0442

10.1111/j.1528-1167.2009.02397.x

Cramer JA, 1994, Neurol Clin, 12, 1, 10.1016/S0733-8619(18)30107-5

Nei M, 2007, Curr Neurol Neurosci Rep, 7, 335, 10.1007/s11910-007-0051-1

Nilsson L, 2002, Epilepsia, 43, 644, 10.1046/j.1528-1157.2002.40001.x

10.1016/0920-1211(95)00090-9

Yoon D, 2009, Epilepsia, 50, 2186, 10.1111/j.1528-1167.2009.02159.x

Ivanova JI, 2010, Pharmacoeconomics, 28, 675, 10.2165/11535570-000000000-00000

Kurth T, 2010, Epilepsia, 51, 874, 10.1111/j.1528-1167.2009.02404.x

Ivanova JI, 2010, Epilepsia, 51, 838, 10.1111/j.1528-1167.2009.02422.x

Lee WC, 2005, Epilepsy Behav, 7, 123, 10.1016/j.yebeh.2005.04.002

Lee WC, 2005, Clin Ther, 27, 1629, 10.1016/j.clinthera.2005.10.020

Davis KL, 2008, Epilepsia, 49, 446, 10.1111/j.1528-1167.2007.01414.x

10.1016/j.yebeh.2008.10.021

Charlson M, 1994, J Clin Epidemiol, 47, 1245, 10.1016/0895-4356(94)90129-5

Ross AP, 2008, Neurology, 71, S21, 10.1212/WNL.0b013e31818f3dcb